CDKN2/p16 predicts survival in oligodendrogliomas: comparison with astrocytomas.

CDKN2/p16 predicts survival in oligodendrogliomas: comparison with astrocytomas.

Item
http://www.wikidata.org/entity/Q48192705
CDKN2A exon-wise deletion status and novel somatic mutations in Indian glioma patients.Genetic alterations of human brain tumors as molecular prognostic factors.CDKN2A loss is associated with shortened overall survival in lower-grade (World Health Organization Grades II-III) astrocytomas.Molecular neuro-oncology and the development of targeted therapeutic strategies for brain tumors. Part 5: apoptosis and cell cycle.Replicative Mcm2 protein as a novel proliferation marker in oligodendrogliomas and its relationship to Ki67 labelling index, histological grade and prognosis.Prognostic value of 1p, 19q, 9p, 10q, and EGFR-FISH analyses in recurrent oligodendrogliomas.Promoter hypermethylation and protein expression of the p16 gene: analysis of 43 cases of B-cell primary gastric lymphomas from China.EZH2 expression in gliomas: Correlation with CDKN2A gene deletion/ p16 loss and MIB-1 proliferation index.CDKN2A deletion in pediatric versus adult glioblastomas and predictive value of p16 immunohistochemistry.Chromosome 1p and 19q status and p53 and p16 expression patterns as prognostic indicators of oligodendroglial tumors: a clinicopathological study using fluorescence in situ hybridization.Molecular markers of prognosis in astrocytic tumors.Impact of 9p deletion and p16, Cyclin D1, and Myc hyperexpression on the outcome of anaplastic oligodendrogliomas.CDKN2A/p16 inactivation in the prognosis of oligodendrogliomas.
P2860

CDKN2/p16 predicts survival in oligodendrogliomas: comparison with astrocytomas.

Item
http://www.wikidata.org/entity/Q48192705
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
CDKN2/p16 predicts survival in oligodendrogliomas: comparison with astrocytomas.
@en
CDKN2/p16 predicts survival in oligodendrogliomas: comparison with astrocytomas.
@nl
type
label
CDKN2/p16 predicts survival in oligodendrogliomas: comparison with astrocytomas.
@en
CDKN2/p16 predicts survival in oligodendrogliomas: comparison with astrocytomas.
@nl
prefLabel
CDKN2/p16 predicts survival in oligodendrogliomas: comparison with astrocytomas.
@en
CDKN2/p16 predicts survival in oligodendrogliomas: comparison with astrocytomas.
@nl
P1433
P1476
P2093
P2888
P304
P31
P356
P433
P478
P577
P6179
P698
P921
P356
P1433
P1476
CDKN2/p16 predicts survival in oligodendrogliomas: comparison with astrocytomas.
@en
P2093
P2888
P304
P31
P356
P433
P478
P577
P6179
P698
P921